| | | | | |
GOF Guggenheim Strategic Opportunities Fund | €8,3049 | -0,83% | €1,87B | €2,32M | |
CMPR Cimpress PLC Ordinary Shares (Ireland) | €77,0927 | +0,34% | €1,87B | €117,68K | |
PVLA Palvella Therapeutics, Inc. Common Stock | €129,31 | -0,37% | €1,86B | €165,60K | |
| €55,7390 | +1,31% | €1,86B | €219,06K | |
ECPG Encore Capital Group, Inc. | €85,3847 | -3,02% | €1,86B | €313,76K | |
EVT Eaton Vance Tax-Advantaged Dividend Income Fund | €24,8630 | -0,48% | €1,86B | €70,92K | |
NMZ Nuveen Municipal High Income Opportunity Fund | €8,6071 | -0,40% | €1,86B | €527,02K | |
| €22,4933 | -9,76% | €1,85B | €1,77M | |
ESTA Establishment Labs Holdings Inc. | €60,9835 | -1,62% | €1,84B | €246,85K | |
BSTZ BlackRock Science and Technology Term Trust | €27,0645 | +0,74% | €1,84B | €127,22K | |
STC Stewart Information Services Corporation | €60,3533 | -0,03% | €1,84B | €251,15K | |
CTRI Centuri Holdings, Inc. | €17,5423 | -3,79% | €1,84B | €1,10M | |
UA Under Armour, Inc. Class C Common Stock, $0.0003 1/3 par value | €4,2733 | -0,20% | €1,83B | €1,88M | |
HAPN Happen, Inc. Common Stock | €15,4488 | -2,98% | €1,83B | €883,23K | |
ZBIO Zenas BioPharma, Inc. Common Stock | €26,9954 | -4,14% | €1,83B | €379,11K | |
